International Harmonization Should Focus On Post-Marketing Activities - HRG
International harmonization efforts should include an emphasis on post-marketing activities, Public Citizen's Health Research Group Deputy Director Peter Lurie, MD, said at an FDA public meeting May 16 on the future of the International Conference on Harmonization.
You may also be interested in...
FDA expects European regulators to begin assessing agency district offices in the next six to eight months, Office of Regulatory Affairs Regional Director Deborah Ralston told a June 5 Food & Drug Law Institute meeting in Washington, D.C.
FDA is working on clarifying issues related to how to structure non-inferiority trials when historical comparisons are necessary.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011